CytoReason vs Genoox
CytoReason vs Genoox, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CytoReason is on 68/100 and Genoox on 62/100.
Where each one leads
CytoReason
- our overall score: 68/100 against 62/100
- headcount: 116 against 53
- headcount growth: +13.7% against +10.7%
- funding raised: $128M against $20.0M
- LinkedIn following: 12,830 against 3,902
Genoox
- agent readiness: 38/100 against 21/100
- domain rating: 50/100 against 40/100
At a glance
| Measure | CytoReason | Genoox |
|---|---|---|
| What it is | Develops a computational model of the human body for drug discovery and development. | Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations. |
| Category | Healthcare, Drug Discovery, Clinical Development, Biomarkers | Healthcare, Genomics, Genomic Data, Next Generation Sequencing |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2016 | 2014 |
| Headquarters | Tel Aviv, Israel | Palo Alto, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | CytoReason | Genoox |
|---|---|---|
| Employees | 116 | 53 |
| Headcount growthLast 12 months | +13.7% | +10.7% |
| Total funding | $128M | $20.0M |
| Latest round | Series B | Series C |
| LinkedIn followers | 12,830 | 3,902 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CytoReason | Genoox |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 68/100 | 62/100 |
| Traction | 60/100 | 54/100 |
| Team | 70/100 | 70/100 |
| Community | Not published | 8/100 |
| Search visibility | 30/100 | 32/100 |
| Quality | 78/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (38/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 50/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CytoReason | Genoox |
|---|---|---|
| CDN | Not detected | Cloudflare |
| Frameworks | Not detected | Angular |
| Analytics | Segment | Not detected |
CytoReason vs Genoox: common questions
Which is better, CytoReason or Genoox?
On our 0-100 score CytoReason rates higher (68/100 against 62/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do CytoReason and Genoox compare on the numbers?
CytoReason leads on our overall score (68/100 against 62/100), headcount (116 against 53), headcount growth (+13.7% against +10.7%), funding raised ($128M against $20.0M), LinkedIn following (12,830 against 3,902). Genoox leads on agent readiness (38/100 against 21/100), domain rating (50/100 against 40/100).
Read the full CytoReason review and pricing or the Genoox review and pricing. You can also browse other CytoReason alternatives we track.